Keywords: GIST; gastrointestinal stromal tumor; CT; computed tomography; PET-CT; positron emission tomography-computed tomography; EUS-FNA; endoscopic ultrasound-guided fine needle aspiration; ICS; intercostal space; Thoracoscopic enucleation; Esophageal leiomyoma;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Asthma; Composite marker; Nitric oxide; Serum periostin; Type-2/eosinophilic inflammation; FeNO; fraction of exhaled nitric oxide; FEV1; forced expiratory volume in 1 s; ICS; inhaled corticosteroid; IgE; immunoglobulin E; IL; interleukin; iNOS; inducible
Keywords: Occupational asthma; Blood eosinophil count; Sputum eosinophil count; Airway responsiveness; AUC; Area under the curve; CI; Confidence interval; HMW; High-molecular weight agent; ICS; Inhaled corticosteroids; IQR; Interquartile ranges; LMW; Low-molecular
Keywords: Severe asthma phenotypes; SARP; Endotype; Precision medicine; Biomarker; Cluster analysis; DREAM; Dose-Ranging Efficacy And safety with Mepolizumab; FeNO; Fractional excretion of nitric oxide; FEV1; Forced expiratory volume in 1 second; ICS; Inhaled corti
Keywords: Nonpharmacologic therapy; Bronchial thermoplasty; Pulmonary rehabilitation; Breathing techniques; AIR; Asthma Intervention Research; BT; Bronchial thermoplasty; BBT; Buteyko breathing technique; COPD; Chronic obstructive pulmonary disease; ED; Emergency d
Keywords: bronchiectasis; inhaled antibiotics; inhaled corticosteroids; macrolides; aOR; adjusted OR; BRR; Bronchiectasis and NTM Research Registry; ICS; inhaled corticosteroid; LABA; long-acting beta agonists; NTM; nontuberculous mycobacteria; NTMir; NTM Info & Re
Keywords: Asthma; Pregnancy; Exacerbation; Macrophage; CD163; Inflammation; Eosinophil; Exhaled nitric oxide; BMI; Body mass index; CRP; C-reactive protein; Feno; Fractional exhaled nitric oxide; GWG; Gestational weight gain; ICS; Inhaled corticosteroid; OCS; Oral
Keywords: Allergy; atopy; bronchiolitis; child; eczema; rhinovirus; respiratory syncytial virus; sensitization; virus; wheeze; wheezing; API; Asthma Predictive Index; ICS; Inhaled corticosteroid; OCS; Oral corticosteroid; OR; Odds ratio; RSV; Respiratory syncytial
Keywords: AMP; Dry powder adenosine; ICS; Provocation; Small airways;
Keywords: asthma; Medicaid; readmission; ED; Emergency department; ICS; Inhaled corticosteroids; OCS; Oral corticosteroid;
Keywords: bronchopulmonary dysplasia; prematurity; pulmonary morbidity; wheeze; BD; Bronchodilator; BPD; Bronchopulmonary dysplasia; ELGAN; Extremely low gestational age newborn; GA; Gestational age; ICS; Inhaled corticosteroids; iNO; Inhaled nitric oxide; NO CLD;
Keywords: Adrenaline; Allergen immunotherapy; Anaphylaxis; Epinephrine; Safety; Sublingual immunotherapy; Systemic allergic reaction; AE; Adverse event; AR/C; Allergic rhinitis with or without conjunctivitis; BAU; Bioequivalent allergen units; HDM; House dust mite;
Keywords: Asthma Control Test; Asthma; Short-acting beta-agonist; Bronchodilator agents; Asthma exacerbation; Asthma rescue medication; ACT; Asthma Control Test; AUC; Area under the curve; ICS; Inhaled corticosteroid; MDI; Metered-dose inhaler; NPV; Negative predic
Keywords: ICS; Inhaled corticosteroids; LABA; Long acting beta-agonist; SABA; Short-acting beta-agonist; GC; gluco-corticosteroids; SDB; Sleep disordered breathing;
Keywords: COPD; Chronic obstructive pulmonary disease; ICS; Inhaled corticosteroids; IL; Interleukin; LABA; Long-acting β2 agonist; NTHi; Non-typeable Haemophilus influenzae; Th; T helper; Animal models; Cigarette smoke; COPD; IL-17;
Keywords: COPD; chronic obstructive pulmonary disease; ICS; inhaled corticosteroid; LABA; long-acting β2-agonist;
Keywords: Biologic therapy; Comorbidities; Adherence; Inhaled corticosteroid; Phenotype; Severe asthma; ABPA; Allergic bronchopulmonary aspergillosis; AERD; Aspirin-exacerbated respiratory disease; COPD; Chronic obstructive pulmonary disease; CRS; Chronic rhinosinu
Keywords: Asthma; Asthma exacerbation; Viral infection; Allergy; Prevention; Treatment; Inhaled corticosteroids; Long-acting β2-agonists; Leukotriene antagonist; Anticholinergics; Anti-IgE; Anti-IL5; Systemic corticosteroids; ED; Emergency department; FEV1; Forced
Keywords: Childhood severe asthma; Difficult to treat asthma; Severe asthma phenotypes; Severe asthma treatment; Review; EPA; Environmental Protection Agency; ETS; Environmental tobacco smoke; FDA; Food and Drug Administration; ICS; Inhaled corticosteroid; LABA; Lo
Keywords: Eosinophils; biomarkers; severe eosinophilic asthma; DREAM; Dose Ranging Efficacy and safety With Mepolizumab in Severe Asthma; Feno; Fraction of exhaled nitric oxide; GINA; Global Initiative for Asthma; ICS; Inhaled corticosteroid; MENSA; Mepolizumab Adj
Keywords: FeNO; fractional exhaled nitric oxide; FEV1; forced expiratory volume in one second; GWAS; genome-wide association study; ICS; inhaled corticosteroids; IL1RL1; interleukin 1 receptor-like 1; LD; linkage disequilibrium; SNP; single nucleotide polymorphism;
Keywords: ACOS; asthma-COPD overlap syndrome; BD; bronchodilation; CARAT; control of allergic rhinitis and asthma test; COPD; chronic obstructive pulmonary disease; FENO; fractional exhaled nitric oxide; FEV1; forced expiratory volume in 1Â s; FVC; forced vital cap
Keywords: Asthma flare; acute asthma; asthma attack; wheezing; acute asthma diagnosis; acute asthma management; COPD; Chronic obstructive pulmonary disease; EPR-3; Expert Panel Report 3; ICS; Inhaled corticosteroid; MDI; Metered-dose inhaler; NPPV; Noninvasive posi
Keywords: AE; adverse event; ClfA; clumping factor A; cLIA; four-plex competitive Luminex® immunoassay; CI; confidence interval; CP; capsular polysaccharide; CRM197; diphtheria toxin; DMC; data monitoring committee; FBI; fibrinogen-binding inhibition; FDA; Food an
Keywords: Asthma; Control; Biologics; Eosinophilic asthma; Severe asthma; Uncontrolled asthma; DDP-4; dipeptidyl peptidase 4; Feno; fraction of exhaled nitric oxide; GINA; Global Initiative for Asthma; ICS; inhaled corticosteroid; LABA; long-acting beta2 agonist; S
Keywords: hMab; humanized monoclonal antibody; ICS; inhaled corticosteroids; ILC2; innate type 2 lymphocytes; LABA; long-acting β2-agonist; Th2; T helper 2; TSLP; thymic stromal lymphopoietin;
Keywords: Omalizumab; Allergic asthma; IgE; Meta-analysis; Effectiveness; ACT; Asthma Control Test; AQLQ; Asthma-related Quality-of-Life Questionnaire; FEV1; Forced expiratory volume in 1 second; GETE; Global Evaluation of Treatment Effectiveness scale; ICS; Inhale
Keywords: Adherence; Asthma; CMA; Inhaled corticosteroids; OPCRD; Pharmacoepidemiology; Cohort study; ICS; Inhaled corticosteroid; CMA; Continuous medication availability; OPCRD; Optimum Patient Care Research Database; ID; Index prescription date;
Keywords: Severe asthma; Severe recurrent wheeze phenotypes; Children; Bacterial infection; Gastroesophageal reflux; Multiple allergies; BMI; Body mass index; FP; Fluticasone propionate; GERD; Gastroesophageal reflux; ICS; Inhaled corticosteroid; LTRA; Leukotriene
Keywords: Childhood asthma; Phenotype; Refractory asthma; Severe asthma; Gene expression; Corticosteroid; ACQ; Asthma Control Questionnaire; AQLQ; Asthma Quality of Life Questionnaire; ICS; inhaled corticosteroid; PBMC; peripheral blood mononuclear cell; SABA; shor
Keywords: Steroid response; asthma; fluticasone; genome-wide association studies; inhaled corticosteroids; pharmacogenetics; 1000G; 1000 Genomes Project; FF; Fluticasone furoate; FP; Fluticasone propionate; GWAS; Genome-wide association study; ICS; Inhaled corticos
Keywords: CN; CargoNet; GC; Green Cargo; ICF; Intercontainer-Interfrigo; ICS; Intercontainer Scandinavia AB; IFT; intermodal freight transport; RC; Rail Combi; RR; Real Rail; SJ; Swedish State Railways; Case study; Business models; Intermodal transport; Deregulatio
Keywords: Allergy; asthma; IgE; omalizumab; pediatric; AA; Allergic asthma; AE; Adverse event; EMA; European Medicines Agency; EXCELS; Epidemiologic Study of Xolair (omalizumab): Evaluating Clinical Effectiveness and Long-term Safety in Patients with Moderate-to-Se
Keywords: Asthma; Adult-onset; Late-onset; Cluster analysis; Phenotypes; Follow-up; Longitudinal; Smoking; Obesity; Early-onset; ACOS; Asthma-COPD overlap syndrome; ACT; Asthma control test; AQ20; Airways Questionnaire 20; BD; Bronchodilator; COPD; Chronic obstruct
Keywords: EIB; exercise-induced bronchoconstriction; BPT; bronchial provocation test; AHR; airway hyperresponsiveness; Mch; methacholine; EVH; Eucapnic Voluntary Hyperpnoea; EIRS; exercise-induced respiratory symptoms; FEV1; forced expiratory volume in 1Â s; PD20;
Keywords: Asthma; sputum; inflammation; sensitization; inner city; ACT; Asthma Control Test; BMI; Body mass index; DTT; Dithiothreitol; Foxp3; Forkhead box p3; ICS; Inhaled corticosteroid; MFI; Median fluorescence intensity; Mini-AQLQ; Mini-Asthma Quality of Life Q
Keywords: Asthma; Attack; Control; Medical record; Observational; Risk factor; ICS; Inhaled corticosteroid; LABA; Long-acting β2 agonist; OCS; Oral corticosteroid; OPCRD; Optimum Patient Care Research Database;
Keywords: Administrative data; Corticosteroid; Comorbidities; Allergist; Asthma specialist; Asthma control; Blood eosinophil count; Chronic oral corticosteroid use; Controller medication; Exacerbations; Asthma guidelines; Managed care; Persistent asthma; Short-acti
Keywords: Cybersecurity; Indoor positioning; Robotics; Cyber-attack; Beacon; Statistical-testing; AOA; Angle of Arrival; CUSUM; Cumulative Sum; DoS; Denial of Service; GPS; Global Positioning System; ICS; Industrial Control System; IDS; Intrusion Detection System;
Keywords: Asthma; direct costs; indirect costs; national asthma program; public health; ICS; Inhaled corticosteroid; LABA; Long-acting β2-agonist; SII; Finnish Social Insurance Institution;
Keywords: aging; airway inflammation; airway obstruction; asthma; biomarkers; ACSS; Asthma Control Scoring System; CC16; Clara-cell protein 16; CCL18-PARC; ratio of CC-chemokine ligand 18/pulmonary and activation-regulated chemokine; CRP; C-reactive protein; ICS; i
Keywords: ICS; SCADA; Cyber; Security; Triage; Risk;
Keywords: aerosols; asthma; COPD; inhalers; small airways; small particles; BDP; beclomethasone dipropionate; CFC; chlorofluorocarbon; DPI; dry powder inhaler; GSD; geometric standard deviation; HFA; hydrofluoroalkane; ICS; inhaled corticosteroid; LABA; long-acting
Keywords: CSE; Cigarette smoke extracts; FP; Fluticasone propionate; FO; Formoterol fumarate dehydrate; GR; Glucocorticoid receptor; NF-κB; Nuclear factor-κB; ERK; Extracellular signal-regulated kinase1/2; HDAC2; Histone deacetylase 2; HDAC3; Histone deacetylase
Keywords: Adenosine 5-monophosphate; Asthma; Bronchial hyperresponsiveness; Children; Inhaled corticosteroid; ICS; inhaled corticosteroid; BHR; bronchial hyperresponsiveness; eNO; exhaled nitric oxide; FEV1; forced expiratory volume in one second; FVC; forced vital
Keywords: Adult asthma; Severe asthma; Exacerbation; Smokers; Predictors; ACQ; asthma control questionnaire; AQLQ; asthma quality of life questionnaire; BMI; body mass index; FeNO; fraction of exhaled nitric oxide; FEV1; forced expiratory volume in 1Â s; FVC; force
Keywords: Exercise-induced cough; Exercise-induced bronchospasm; PE classes'; Schoolchildren; PE; physical education; ETC; exercise treadmill challenge; ICS; inhaled corticosteroids; EIB; exercise-induced bronchospasm; FEV1; forced expiratory volume in 1Â s; SPT; s
Keywords: Asthma; Adult-onset; Asthma duration; Childhood-onset; Elderly; Inflammatory biomarker; ACQ; Asthma control questionnaire; AQLQ; Asthma quality of life questionnaire; ATS; American Thoracic Society; BMI; Body mass index; BTS; British Thoracic Society; CAP
Keywords: Asthma; Therapy; Hospitalizations; Treatment profiles; COPD; chronic obstructive pulmonary disease; EGB; General Sample of Beneficiaries; FDC; fixed-dose combination; GPs; general practitioners; ICD-10; International Classification of Diseases, 10th Revis
Keywords: Asthma; Children; Controller medications; Adherence; Provider; ED; emergency department; HPHC; Harvard Pilgrim Health Care; ICS; inhaled corticosteroids; ICS/LABA; inhaled corticosteroids/long-acting beta-agonist; LTRA; leukotriene antagonist; OR; odds ra